Skip to main content
Figure 5 | Proteome Science

Figure 5

From: Prediction of outcome of non-small cell lung cancer patients treated with chemotherapy and bortezomib by time-course MALDI-TOF-MS serum peptide profiling

Figure 5

Comparison serum profiles NSCLC vs. cancer-free controls. A, Principle Component Analysis (PCA) NSCLC vs. cancer-free control comparison. B, heat map of the 47 differential peaks. The peaks are ordered by median fold change between the two groups. C, spectra overlay of the 8 most differential peaks in the healthy (red) versus NSCLC (blue) comparison. Spectra overlay of the 8 peaks randomly selected out of the remaining 635 peptides.

Back to article page

Proteome Science

ISSN: 1477-5956